CHA Biotech seeks to resume healthcare unit IPO after affiliates’ merger

CHA Biotech seeks to resume healthcare unit IPO after affiliates’ merger

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a m...

CHA Healthcare incorporates Singapore's SMG as subsidiary

CHA Healthcare incorporates Singapore's SMG as subsidiary

South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare an...

Bubble tea chain Gong Cha struggles in its top market of Korea

Bubble tea chain Gong Cha struggles in its top market of Korea

Global leading bubble tea franchise Gong Cha Global Ltd.’s South Korean affiliate, which owns the beverage chain’s Japanese and Taiwanes...

Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025

Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025

CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...

Cha Biotech sells eye-cell technology to Japan's Astellas for $32 mn

Cha Biotech sells eye-cell technology to Japan's Astellas for $32 mn

Cha Biotech, a South Korean biotechnology company, said on Thursday that it agreed to sell its technology for developing eye-cell therapies to Astel...

Korea's Cha Bio Group to expand overseas real estate business

Korea's Cha Bio Group to expand overseas real estate business

Cha Bio Group, consisting of Cha Biotech and Cha Vaccine Research Institute as its subsidiaries, has announced its expansion into the real estate in...

CHA Healthcare buys major Australian fertility center

CHA Healthcare buys major Australian fertility center

South Korea’s medical center operator CHA Healthcare Co. said on Monday it has acquired the management rights of Fertility Specialists of West...

Korea’s CHA Biotech to triple US CDMO capacity

Korea’s CHA Biotech to triple US CDMO capacity

CHA Biotech, South Korea’s stem cell therapeutics developer, is set to expand its biomaterials contract development and manufacturing organiza...

Former KIC real estate head to serve as ADQ's chief investment officer

Former KIC real estate head to serve as ADQ's chief investment officer

Cha Hoon, the former head of real estate investment at Korea Investment Corporation (KIC) is moving to Abu Dhabi’s state holding firm Abu Dhab...

Real estate investment head resigns from KIC

Real estate investment head resigns from KIC

The head of real estate investment at Korea Investment Corporation (KIC) has resigned from the South Korean sovereign wealth fund. Cha Hoon, appoint...

Unison Capital agrees to sell Gong Cha to US PEF for $300 mn

Unison Capital agrees to sell Gong Cha to US PEF for $300 mn

South Korea-based Unison Capital Inc. has signed a definitive agreement to sell milk tea brand Gong Cha to US private equity firm TA Associates for ar...

Unison Capital in final stages of talks to sell Gong Cha to US PEF

Unison Capital in final stages of talks to sell Gong Cha to US PEF

Unison Capital Inc. is in the final stages of negotiations to sell Taiwan-style milk tea brand Gong Cha to US private equity firm TA Associates for ar...

Unison Capital puts bubble tea franchise Gong Cha up for sale

Unison Capital puts bubble tea franchise Gong Cha up for sale

Private equity firm Unison Capital Inc. has put bubble tea franchise Gong Cha on the market, a deal estimated at up to $442 million, as the South Kore...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared